Shorted
Percheron Therapeutics logo
PER
Pharmaceuticals, Biotechnology & Life Sciences

Percheron Therapeutics

Short interest
0.02%
−0.14 pp 30d
as of 21 Feb 2025
Reported shorts
237.1K
Shares on issue
1.087B

Percheron Therapeutics (PER) company profile

Profile, insiders and operations

Director trades

20 trades recorded

DateDirectorTypeSharesPriceValue
2026-10-08Michael Baker
buy
75,000,000--
2026-10-08Unknown Director
buy
---
2026-08-31James Garner
sell
2,672,500--
2026-08-31Unknown Director
buy
---
2026-04-15James Garner
other
32,100,000$0.003$107,000
2026-04-15Unknown Director
buy
---
2025-12-30Dr Ben Gil Price
buy
---
2025-12-23Dr James Garner
buy
---
2025-12-22Ben Gil Price
buy
2,000,000$0.009$17,220.06
2025-12-19James Garner
buy
1,000,000$0.009$8,500
2025-07-01Dr James Garner
buy
---
2025-06-30James Garner
buy
2,500,000$0.010$24,960
2025-05-20James Garner
other
5,000,000$0.035$175,000
2025-05-20Charmaine Gittleson
buy
239,999$0.035$8,399.97
2025-05-20Dr James Garner
buy
---
2025-05-20Dr Charmaine Gittleson
buy
---
2025-04-03Dr Ben Gil Price
buy
---
2025-03-31Ben Gil Price
buy
5,000,000$0.012$58,121.02
2025-03-31Dr James Garner
buy
---
2025-03-28James Garner
buy
7,500,000$0.011$81,870.8

PER intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required